Drug-labels.com

M-Diltiazem T: Uses, Side Effects and Dosage

Status:
Prescription (Rx) Facts
Strength:
120 mg, 180 mg, 240 mg, 300 mg, 360 mg
Active ingredient:
ATC code:
Similar drugs:

Patient Medication Information: uses, side effects, how to take - M-Diltiazem T

What M-DILTIAZEM T is used for:

M-DILTIAZEM T is used in adults to:

  • treat mild to moderate high blood pressure.
  • control chest pain that most often occurs with physical activity or emotional stress (chronic stable angina). It can be used with other chest pain medicines when those medicines do not provide enough benefit on their own. M-DILTIAZEM T is normally used in patients who have tried other treatments for their chest pain, but did not receive benefits, or had bad side effects.

How M-DILTIAZEM T works:

M-DILTIAZEM T belongs to the group of drugs called “calcium channel blockers” or “calcium antagonists”.

  • M-DILTIAZEM T relaxes the arteries, which allows blood to flow freely through them. This helps to lower blood pressure.
  • M-DILTIAZEM T reduces the amount of oxygen that your heart muscle needs. This helps control chest pain.

The ingredients in M-DILTIAZEM T are:

Medicinal ingredient: diltiazem hydrochloride

Non-medicinal ingredients: Ethyl Cellulose, Gelatin, Hypromellose, Isopropyl alcohol, Methylene Chloride, Sodium Lauryl Sulphate, Sugar Spheres (pharma A Spheres), Talc, Titanium Dioxide, Triethyl Citrate.

In addition, the different strengths of M-DILTIAZEM T may also contain one or more of the following dyes: D&C Yellow #10, FD&C Blue #1, FD&C Green #3, FD &C Red #3.

M-DILTIAZEM T comes in the following dosage forms:

Extended-release capsules: 120 mg, 180 mg, 240 mg, 300 mg and 360 mg.

M-DILTIAZEM T (Diltiazem Hydrochloride Extended-Release Capsules) Page 32 of 39

Do not use M-DILTIAZEM T if:

  • you are allergic to diltiazem or any other ingredients in M-DILTIAZEM T or its container.
  • you have any heart rhythm disorders and do not have a pacemaker.
  • you have very low blood pressure (less than 90 mmHg systolic).
  • you have a very slow heartbeat (less than 40 beats/minute).
  • you have had a heart attack and have fluid in your lungs as a result of heart failure.
  • you are pregnant or plan to become pregnant.
  • you are a woman of child-bearing potential, unless you and your healthcare professional have decided you should take M-DILTIAZEM T.
  • you are breastfeeding or planning to breastfeed.
  • you are taking the following medicines:

    • dantrolene, used to treat severe muscle spasms or severe fever;
    • ivabradine, used to treat heart failure;
    • lomitapide mesylate, used to treat high blood cholesterol.

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take M-DILTIAZEM T. Talk about any health conditions or problems you may have, including if you:

  • have heart, liver or kidney disease.
  • had a recent heart attack.
  • have high blood sugar or diabetes.
  • are at risk of developing an intestinal obstruction.
  • are 65 years of age or older.
  • have a history of heart failure, new shortness of breath, slow heartbeat or low blood pressure. Cases of kidney injury in patients with such conditions have been reported.
  • have asthma or other breathing problems. M-DILTIAZEM T may cause your symptoms to get worse after a dose increase.

Other warnings you should know about:

M-DILTIAZEM T can cause serious side effects, including:

  • Kidney problems: M-DILTIAZEM T can cause kidney problems, even at prescribed doses. You are at higher risk if you have heart failure, a very slow heartbeat or very low blood pressure.
  • Hyperglycemia (high blood sugar): M-DILTIAZEM T may affect your blood sugar. If you have diabetes, closely monitor your blood sugar while taking M-DILTIAZEM T and report any unusual results to your healthcare professional.

See the Serious side effects and what to do about them table for more information on these and other serious side effects.

Surgery: Tell any doctor, dentist, pharmacist or healthcare professional that you see, that you are taking this medicine. This is especially important if you are planning to have surgery (including dental procedures).

Pregnancy:

  • Avoid becoming pregnant while you are taking M-DILTIAZEM T. If you are able to get pregnant, you should use effective birth control (contraception) during your treatment. Talk to your healthcare professional about the best kind of birth control to use while you are taking M-DILTIAZEM T.
  • If you take M-DILTIAZEM T during pregnancy, it may harm your unborn baby. Your healthcare professional will discuss the risks with you.
  • If you discover that you are pregnant, stop taking M-DILTIAZEM T and tell your healthcare professional right away.

Breastfeeding: M-DILTIAZEM T passes into breast milk and may harm your baby. Do not breastfeed during treatment with M-DILTIAZEM T. Talk to your healthcare professional about ways to feed your baby during this time.

Adults (65 years of age or older): Side effects like swelling of the arms or legs, irregular heartbeat, dizziness, skin rash and frequent urination may happen more often. Your healthcare professional might adjust your dose of M-DILTIAZEM T. They will monitor your health during and after treatment.

Checks-up and testing:

  • You will have regular visits with your healthcare professional while you are taking M-DILTIAZEM T to monitor your health. They will:

    • do blood and urine tests to check your liver and kidney health, and the level of sugar in your blood;
    • check your lungs and verify if you have any breathing problems.
  • M-DILTIAZEM T can cause abnormal blood test results. Your healthcare professional will decide when to perform blood tests and will interpret the results.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

Serious Drug Interactions

Do not take M-DILTIAZEM T with:

  • dantrolene, used to treat severe muscle spasms or severe fever;
  • ivabradine, used to treat heart failure;
  • lomitapide mesylate, used to treat high blood cholesterol.

Serious drug interactions with M-DILTIAZEM T include:

  • medicines used to prevent and treat blood clots (Direct Oral Anticoagulants (DOACs)) such as dabigatran, rivaroxaban, apixaban.

Taking M-DILTIAZEM T with any of these medicines may cause serious drug interactions. Ask your healthcare professional if you are unsure you are taking these medicines.

The following may also interact with M-DILTIAZEM T:

  • medicines used to treat fungal infections with a name ending in “azole”;
  • medicines used to treat bacterial infections, such as rifampin, erythromycin, clarithromycin;
  • medicines used to treat high blood pressure, such as alpha antagonists, beta blockers;
  • heart medications, such as amiodarone, digoxin, digitalis, flecainide, nifedipine, propafenone, quinidine, verapamil;
  • medicines used to treat chest pain (angina), such as short or long acting nitrates;
  • medicines used to control seizures, such as carbamazepine, phenytoin, phenobarbital;
  • medicines used to lower blood cholesterol, such as “statins”;
  • medicines used to reduce stomach acid and treat ulcers in the stomach or intestines, such as cimetidine, ranitidine;
  • medicines used to treat inflammation, such as corticosteroids (including methylprednisolone);
  • acetylsalicylic acid (ASA, or ASPIRIN) or medicines used to prevent blood clots, such as ticagrelor, cilostazol, clopidogrel, dipyridamole, ticlopidine, warfarin;
  • sleeping pills, such as benzodiazepines (midazolam, triazolam);
  • anesthetics;
  • cyclosporine, used to control the immune system;
  • lithium, used to treat bipolar disorder;
  • imipramine, used to treat depression;
  • theophylline, used to treat asthma or other lung diseases;
  • terfenadine, used to treat allergies;
  • ritonavir, used to treat HIV/AIDS;
  • products that contain calcium such as multivitamins with minerals;
  • X-ray contrast agents.

Alcohol

Drinking alcohol while taking M-DILTIAZEM T may cause low blood pressure and dizziness when you go from lying or sitting to standing up. This is more likely to occur after the first dose or when the dose is increased. Tell your doctor if you experience dizziness, light-headedness, fainting, decreased blood pressure or increased heart rate.

Grapefruit juice

Drinking grapefruit juice while taking M-DILTIAZEM T may cause headache, irregular heartbeat, edema (swelling), unexplained weight gain, and chest pain. Tell your doctor if this happens to you. Your doctor may recommend that you avoid grapefruit juice while taking M-DILTIAZEM T.

How to take M-DILTIAZEM T:

  • Take M-DILTIAZEM T exactly as your healthcare professional tells you.
  • M-DILTIAZEM T is taken once a day at about the same time every day.
  • DO NOT chew or crush M-DILTIAZEM T capsules.

Usual dose:

High Blood Pressure: the usual starting dose is 180 to 240 mg once a day. 120 mg a day may be used in some patients. Maximum dose: 360 mg a day.

Chest Pain (angina): your doctor will decide the best dose for you. The usual starting dose is 120 mg to 180 mg once a day. Your dose may be slowly increased (over 7 to 14 days) up to 360 mg once a day.

Overdose:

Signs of an overdose with M-DILTIAZEM T include:

  • very slow or irregular heartbeat.
  • very low blood pressure.
  • kidney problems.
  • heart does not pump blood as well as it should or suddenly stops beating.

If you think you, or a person you are caring for, have taken too much M-DILTIAZEM T, contact a healthcare professional, hospital emergency department, regional poison control centre or Health Canada’s toll-free number, 1-844 POISON-X (1-844-764-7669) immediately, even if there are no signs or symptoms.

Missed Dose:

If you miss a dose, take it as soon as possible. However, if it is almost time for the next dose, skip the missed dose and take your next dose as scheduled. Do not take two doses at the same time.

Possible side effects from using M-DILTIAZEM T:

These are not all the possible side effects you may feel when taking M-DILTIAZEM T. If you experience any side effects not listed here, tell your healthcare professional.

  • Headache, dizziness, malaise;
  • Nausea (feeling like vomiting);
  • Flushing (facial redness) or feeling unusually warm;
  • Rash;
  • Temporary swelling;
  • Unusual tiredness and weakness;
  • Upset stomach or indigestion.

Serious side effects and what to do about them

Serious side effects and what to do about them
Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
Only if severeIn all cases
COMMON
Allergic reaction: rash, hives, swelling of the face, lips, tongue or throat, difficulty swallowing or breathing√
Fast, slow or irregular heartbeat√
Hypotension (low blood pressure): dizziness, fainting, light-headedness, blurred vision, nausea, vomiting, fatigue (may occur when you go from lying or sitting to standing up)√
Peripheral edema: (swelling of the legs or hands): swollen or puffy legs, ankles or hands, feeling heavy, achy or stiff√
Respiratory tract infection: (a cold): runny or stuffy nose, sore throat, cough, sinus congestion, body aches, headache, sneezing, fever, generally feeling unwell√
UNCOMMON
Angina (chest pain): discomfort in the shoulder, arm, back, throat, jaw or teeth; pain or pressure in the chest√
Depression: (sad mood that won’t go away): difficulty sleeping or sleeping too much, changes in appetite or weight, feelings of worthlessness, guilt, regret, helplessness or hopelessness, withdrawal from social situations, family, gatherings and activities with friends, reduced libido (sex drive) and thoughts of death or suicide. If you have a history of depression, your depression may become worse√
Eye problems: blurred vision, loss of vision in the eye, increased sensitivity of the eyes to light, eye pain or redness, swelling and itching of the eyelids√
Heart block (a disease in the electrical system of the heart): light-headedness, fainting, irregular heartbeat√
Heart failure: shortness of breath, fatigue and weakness, leg swelling in legs, ankles and feet, cough, lack of appetite, nausea, rapid or irregular heartbeat, reduced ability to exercise√
Hyperglycemia: (high blood sugar): increased thirst and hunger, frequent urination, thirst, and hunger headache, blurred vision, fatigue√
RARE
Kidney problems: nausea, vomiting, fever, swelling of extremities, fatigue, thirst, dry skin, irritability, dark urine, increased or decreased urine output, blood in the urine, rash, weight gain (from retaining fluid), loss of appetite, abnormal blood test results, mental status changes (drowsiness, confusion, coma)√

M-DILTIAZEM T (Diltiazem Hydrochloride Extended-Release Capsules) Page 38 of 39

Serious side effects and what to do about them
Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
Liver problems: yellowing of the skin or eyes, dark urine, stomach pain or swelling, nausea, vomiting, unusual tiredness√
Severe skin reactions: fever, severe rash, swollen lymph glands, flu-like feeling, blisters and peeling skin that may start in and around the mouth, nose, eyes and genitals and spread to other areas of the body, yellow skin or eyes, shortness of breath, dry cough, chest pain or discomfort, feeling thirsty, urinating less often, less urine√

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, tell your healthcare professional.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (canada.ca/drug-device-reporting) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your healthcare professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

  • Store M-DILTIAZEM T capsules at room temperature (15 - 30°C).
  • Keep out of sight and reach of children.

If you want more information about M-DILTIAZEM T:

  • Talk to your healthcare professional.
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada Drug Product Database website: (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html); or by contacting Mantra Pharma Inc. at

M-DILTIAZEM T (Diltiazem Hydrochloride Extended-Release Capsules) Page 39 of 39

  • medinfo@mantrapharma.ca or at 1-833-248-7326.

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02546434

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for M-Diltiazem T

Rx or OTC
Prescription (Rx)?
DIN 02546434, 02546442, 02546450, 02546469, 02546477
Schedule(s) PRESCRIPTION
Active ingredient(s) Diltiazem hydrochloride
Dosage form(s) Capsule (Extended-Release)
Route(s) of administration Oral
Drug class (WHO ATC)
  1. C Cardiovascular system drugs
    1. C08 Calcium channel blockers
      1. C08D Selective calcium channel blockers with direct cardiac effects
        1. C08DB Benzothiazepine derivative selective calcium channel blockers with direct cardiac effects
          1. C08DB01 Diltiazem
Company MANTRA PHARMA INC
Current status Marketed
Current status date August 23, 2024
Strengths and forms
DIN Strength Dosage form(s) Current status
02546434 120 MG Capsule (Extended-Release) Marketed August 23, 2024
02546442 180 MG Capsule (Extended-Release) Marketed August 23, 2024
02546450 240 MG Capsule (Extended-Release) Marketed August 23, 2024
02546469 300 MG Capsule (Extended-Release) Marketed August 23, 2024
02546477 360 MG Capsule (Extended-Release) Marketed August 23, 2024

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.